Literature DB >> 14656902

Liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma.

Robert E Nelson1, Stefan K Grebe, Dennis J OKane, Ravinder J Singh.   

Abstract

BACKGROUND: Estradiol (E2) and estrone (E1) measurements form an integral part of the assessment of female reproductive function and have expanding roles in other fields. However, many E1 and E2 immunoassays have limited functional sensitivity, suffer from cross-reactivity, and display poor intermethod agreement. To overcome these problems, we developed a sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay for the simultaneous measurement of E1 and E2.
METHODS: After dansyl chloride derivatization, samples were separated by fast gradient chromatography and injected into a tandem mass spectrometer after formation of positive ions with atmospheric pressure chemical ionization. The limits of detection and quantification, recovery, linearity, precision, and reference intervals were determined, and performance was compared with several immunoassays.
RESULTS: Total run time per sample was 5 min. The multiple-reaction monitoring ion pairs were m/z 506/171 for 3-dansyl-estradiol and m/z 504/171 for 3-dansyl-estrone. The limits of detection for E1 and E2 were 12.9 pmol/L (3.5 ng/L) and 10.3 pmol/L (2.8 ng/L), respectively. Interassay imprecision (CV) was 4-20% (n = 20). The limits of quantification (functional sensitivities) for E1 and E2 were 44.1 pmol/L (11.9 ng/L) and 23.2 pmol/L (6.3 ng/L), respectively. The assay was linear to >2200 pmol/L ( approximately 600 ng/L) for each analyte. Recoveries were 93-108% for E1 and 100-110% for E2. No cross-reactivity was observed. Method comparison with several immunoassays revealed that the latter were inaccurate and prone to interferences at low E1 and E2 concentrations.
CONCLUSIONS: LC-MS/MS allows rapid, simultaneous, sensitive, and accurate quantification of E1 and E2 in human serum.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14656902     DOI: 10.1373/clinchem.2003.025478

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  99 in total

1.  Quantification of steroid hormones in low volume plasma and tissue homogenates of fish using LC-MS/MS.

Authors:  Mohammad-Zaman Nouri; Kevin J Kroll; Molly Webb; Nancy D Denslow
Journal:  Gen Comp Endocrinol       Date:  2020-06-27       Impact factor: 2.822

Review 2.  Vaginal estrogen use in postmenopausal women with pelvic floor disorders: systematic review and practice guidelines.

Authors:  David D Rahn; Renée M Ward; Tatiana V Sanses; Cassandra Carberry; Mamta M Mamik; Kate V Meriwether; Cedric K Olivera; Husam Abed; Ethan M Balk; Miles Murphy
Journal:  Int Urogynecol J       Date:  2014-11-13       Impact factor: 2.894

3.  Relation between sex hormone concentrations, peripheral arterial disease, and change in ankle-brachial index: findings from the Framingham Heart Study.

Authors:  Robin Haring; Thomas G Travison; Shalender Bhasin; Ramachandran S Vasan; Henri Wallaschofski; Maithili N Davda; Andrea Coviello; Joanne M Murabito
Journal:  J Clin Endocrinol Metab       Date:  2011-09-21       Impact factor: 5.958

4.  Estimation of estradiol in mouse serum samples: evaluation of commercial estradiol immunoassays.

Authors:  Daniel J Haisenleder; Aleisha H Schoenfelder; Elizabeth S Marcinko; Lisa M Geddis; John C Marshall
Journal:  Endocrinology       Date:  2011-09-20       Impact factor: 4.736

5.  Age disrupts androgen receptor-modulated negative feedback in the gonadal axis in healthy men.

Authors:  Johannes D Veldhuis; Paul Y Takahashi; Daniel M Keenan; Peter Y Liu; Kristi L Mielke; Suanne M Weist
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-08-03       Impact factor: 4.310

6.  Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent manner.

Authors:  Stephanie J Byer; Jenell M Eckert; Nicole M Brossier; Buffie J Clodfelder-Miller; Amy N Turk; Andrew J Carroll; John C Kappes; Kurt R Zinn; Jeevan K Prasain; Steven L Carroll
Journal:  Neuro Oncol       Date:  2010-11-12       Impact factor: 12.300

7.  Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography-tandem mass spectrometry.

Authors:  Micol S Rothman; Nichole E Carlson; Mei Xu; Christina Wang; Ronald Swerdloff; Paul Lee; Victor H H Goh; E Chester Ridgway; Margaret E Wierman
Journal:  Steroids       Date:  2010-11-09       Impact factor: 2.668

8.  Serum estrogen receptor bioactivity and breast cancer risk among postmenopausal women.

Authors:  Vanessa W Lim; Jun Li; Yinhan Gong; Aizhen Jin; Jian-Min Yuan; Eu Leong Yong; Woon-Puay Koh
Journal:  Endocr Relat Cancer       Date:  2014-02-27       Impact factor: 5.678

Review 9.  Vasomotor symptoms: natural history, physiology, and links with cardiovascular health.

Authors:  R C Thurston
Journal:  Climacteric       Date:  2018-02-02       Impact factor: 3.005

10.  A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen.

Authors:  Cynthia A Thomson; H H Sherry Chow; Betsy C Wertheim; Denise J Roe; Alison Stopeck; Gertraud Maskarinec; Maria Altbach; Pavani Chalasani; Chuan Huang; Meghan B Strom; Jean-Philippe Galons; Patricia A Thompson
Journal:  Breast Cancer Res Treat       Date:  2017-05-30       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.